Global Green (GOGC) 10-Q 15 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	13-May-15
Document And Entity Information [Abstract]
Entity Registrant Name	GLOBAL GREEN INC.
Entity Central Index Key	1522724
Trading Symbol	cogc
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		745,761,432
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash	$7,722	$7,833
Travel advances to officer	2,000	2,000
Total current assets	9,722	9,833
Intangible asset, net	5,375	5,459
Total assets	15,097	15,292
Current liabilities:
Accounts payable and accrued expenses	22,372	18,328
Due to shareholders	500	500
Convertible advance- related party (see Note 6)	241,908	221,908
Total liabilities	264,780	240,736
Commitments and Contingencies (see Note 7)
Shareholders' deficit:
Preferred stock; no par value; 100,000,000 shares authorized; no shares outstanding at March 31, 2015 or December 31, 2014
Common stock; $.00001 par value; 3,000,000,000 shares authorized; 745,761,432 shares issued and outstanding at March 31, 2015 and December 31, 2014	7,458	7,458
Additional paid in capital	285,573	285,573
Accumulated deficit	-542,714	-518,475
Total shareholders' deficit	-249,683	-225,444
Total liabilities and shareholders' deficit	$15,097	$15,292

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	745,761,432	745,761,432
Common stock, shares outstanding	745,761,432	745,761,432

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
REVENUES
OPERATING EXPENSES
Professional fees	19,293	9,027
Interest expense (see Note 6)	2,982	3,000
General and administrative	1,400	4,676
Stock transfer agent fees	450	450
Amortization	84	84
Bank Fees	30
Investor Relations		3,000
Total operating expenses	24,239	20,237
NET LOSS	($24,239)	($20,237)
Net loss per share applicable to common stockholders - basic and diluted (in dollars per share)	$0	$0
Weighted average number of shares outstanding - basic and diluted (in shares)	745,761,432	745,761,432

Consolidated_Statements_of_Sha

Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) (USD $)	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2013	$7,458	$285,573	($428,382)	($135,351)
Balance (shares) at Dec. 31, 2013	745,761,432
Increase Decrease In Stockholders Equity [Roll Forward]
Net loss			-90,093	-90,093
Balance at Dec. 31, 2014	7,458	285,573	-518,475	-225,444
Balance (shares) at Dec. 31, 2014	745,761,432			745,761,432
Increase Decrease In Stockholders Equity [Roll Forward]
Net loss			-24,239	-24,239
Balance at Mar. 31, 2015	$7,458	$285,573	($542,714)	($249,683)
Balance (shares) at Mar. 31, 2015	745,761,432			745,761,432

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	($24,239)	($20,237)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	84	84
Change in assets and liabilities:
Travel advances to officer		4,000
Accounts payable and accrued expenses	4,044	-7,759
Net cash used in operating activities	-20,111	-23,912
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible advance - related party	20,000
Repayments on convertible advance - related party		-16,000
Net cash provided by/used in financing activities	20,000	-16,000
NET CHANGE IN CASH	-111	-39,912
CASH, beginning of period	7,833	113,532
CASH, end of period	7,722	73,620
SUPPLEMENTAL DISCLOSURES:
Cash Paid for Interest		$2,916

NATURE_OF_ORGANIZATION

NATURE OF ORGANIZATION	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF ORGANIZATION	NOTE 1                          NATURE OF ORGANIZATION
	Global Green, Inc. (the "Company") is a Florida Corporation incorporated on July 12, 2004 (inception) as a wholly owned subsidiary of Global Assets & Services, Inc.  In September 2004, the Company was spun out into a separate legal entity.  The Company changed its name from The Global Tech Assets, Inc. to Global Green, Inc. in April 2010 and its fiscal period end is December 31.
	The Company is in the development stage.  The principal activities during the development stage include organizing the corporate structure, implementing the Company's business plan and raising capital.  Although the Company was formed in 2004, it did not have any operating activities until 2010.
	Under the Share Exchange Agreement executed on November 29, 2010, between the Company and Nutritional Health Institute, LLC ("NHIL"), the Company acquired 100% of the issued and outstanding stock of Global Green International, Inc. ("GGII"), a wholly owned subsidiary of NHIL. At the same time, the Company issued approximately 683 million shares of its common stock, representing 93% of the ownership of the Company, to NHIL. After the above mentioned acquisition as per the Share Exchange Agreement, the Company has become a majority-owned subsidiary of NHIL. As the effective control over GGII did not change, in accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 805 Business Combinations, GGII is consolidated at its book value (See Note 4).  Prior to November 2010, GGII had no assets or operations, so there was no impact to the historical financial statements.
	GGII, a wholly-owned subsidiary of the Company, has been granted the exclusive worldwide rights (the "Licensing Agreement") to manufacture, distribute, market and sell a Salmonella Antigen and Vaccine (the "Vaccine").  The Licensing Agreement was executed between NHIL and GGII before the Company acquired the 100% ownership of GGII and is the only asset of GGII.
	In February 2011, the Vaccine entered into the final phase of becoming a United States Department of Agriculture ("USDA") approved vaccine for the in ovo vaccination of chicken eggs to provide immunity against Salmonella bacteria. In May 2011, the United States Patent and Trademark Office granted a patent for the method and composition in the Vaccine. In August 2011, an additional patent was granted related to the vaccine.

GOING_CONCERN

GOING CONCERN	3 Months Ended
	Mar. 31, 2015
Going Concern [Abstract]
GOING CONCERN	NOTE 2                          GOING CONCERN
	These consolidated financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future.  As of March 31, 2015, the Company has incurred net losses of $542,714 and a net working capital deficit of $255,058 since inception.
	Management's plans include raising capital through the equity markets to fund operations and eventually, the generating of revenue through its business; however, there can be no assurance that the Company will be successful in such activities.  These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classifications of the liabilities that might be necessary should the Company be unable to continue as a going concern.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3                          SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") on the accrual basis of accounting.  All significant intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements.  The significant accounting policies, estimates and related judgments underlying the Company's consolidated financial statements are summarized below.  In applying these policies, management makes subjective judgments that frequently require estimates about matters that are inherently uncertain.  Actual results could differ materially from those estimates.
	Cash and Cash Equivalents
	The Company considers all investments with a maturity date of three months or less when purchased to be cash equivalents.  There were no cash equivalents at March 31, 2015 and December 31, 2014.
	Revenue Recognition
	The Company recognizes revenue on arrangements in accordance with Securities and Exchange Commission Staff Accounting Bulletin Topic 13, Revenue Recognition and ASC 605-15-25, Revenue Recognition.  In all cases, revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed and collectability is reasonably assured. The Company did not report any revenues for the periods ended March 31, 2015 and 2014.
	Earnings Per Share
	The Company has adopted ASC 260-10-50, Earnings Per Share, which provides for the calculation of "basic" and "diluted" earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Basic and diluted losses per share were the same at the reporting dates as there were no common stock equivalents outstanding at March 31, 2015 and 2014.
	Concentrations
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash.
	Occasionally, cash balances may exceed amounts insured by the Federal Deposit Insurance Corporation ("FDIC").  Accordingly, the Company places its cash and cash equivalents with financial institutions considered by management to be of high credit quality.
	Income Taxes
	Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Additionally, the recognition of future tax benefits, such as net operating loss carryforwards, is required to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the assets and liabilities are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income tax expense in the period that includes the enactment date.
	In the event the future tax consequences of differences between the financial reporting bases and the tax bases of the Company's assets and liabilities result in deferred tax assets, an evaluation of the probability of being able to realize the future benefits indicated by such asset is required. A valuation allowance is provided for the portion of the deferred tax asset when it is more likely than not that some or all of the deferred tax asset will not be realized. In assessing the realizability of the deferred tax assets, management considers the scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies.
	The Company files income tax returns in the United States and Florida, which are subject to examination by the tax authorities in these jurisdictions. Generally, the statute of limitations related to the Company's federal and state income tax return is three years. The state impact of any federal changes for prior years remains subject to examination for a period up to five years after formal notification to the states.
	Management has evaluated tax positions in accordance with ASC 740, Income Taxes, and has not identified any significant tax positions, other than those disclosed.
	Subsequent Events
	In accordance with ASC 855, Subsequent Events, the Company evaluated subsequent events through May 8, 2015, the date the consolidated financial statements were available for issue.

INTANGIBLE_ASSET

INTANGIBLE ASSET	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSET	NOTE 4                         INTANGIBLE ASSET
	The Company accounts for its intangible asset in accordance FASB ASC 350 Intangibles—Goodwill and Other.  The intangible assets consist of the Licensing Agreement and is carried at an allocated cost, less accumulated amortization.  The Licensing Agreement was executed on November 29, 2010 between NHIL and GGII, before the Company acquired the 100% ownership of GGII as described in Note 1. The provisions in the License Agreement include the Company's responsibilities to protect the Vaccine information and to assume financial responsibilities for the acquisition of USDA approval of the Vaccine.  The License Agreement has no expiration date, but is being amortized over the 20 year legal life of the related patent. As the effective control over GGII did not change after acquisition by the Company, in accordance with ASC 805, Business Combinations, the License Agreement is consolidated at the book value.  At March 31, 2015 and 2014, the company recorded amortization expense of $84.  The Company expects amortization expense to be approximately $336 per year for each of the next five fiscal years.
	Components of intangible assets at the periods ended are as follows:
		31-Mar-15			31-Dec-14
	License Agreement	$	6,831		$	6,831
	Accumulated amortization		(1,456	)		(1,372	)
	Intangible assets, net	$	5,375		$	5,459

TAXES

TAXES	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
TAXES	NOTE 5                          TAXES
	The components of income tax benefit for the years ended are as follows:
		31-Mar-15			31-Mar-14
	Current tax benefit	$	(9,114	)	$	(7,609	)
	Change in valuation allowance		9,114			7,609
		$	-		$	-
	The difference between income tax benefit computed by applying the statutory federal income tax rate to earnings before taxes for the years ended are as follows:
		31-Mar-15			31-Mar-14
	Pretax loss at federal statutory rate	$	(8,241	)	$	(6,881	)
	State income benefit, net of federal benefit		(873	)		(729	)
	Change in valuation allowance		9,114			7,609
		$	-		$	-
	The components of deferred taxes are as follows:
		31-Mar-15			31-Dec-14
	Deferred income tax assets:
	Operating loss carryforwards	$	204,062		$	194,948
	Less: Valuation allowance		(204,062	)		(194,948	)
		$	-		$	-
	At March 31, 2015 and December 31, 2014, a valuation allowance was established for the entire amount of the net deferred tax asset as the realization of the deferred tax asset is dependent on future taxable income.
	At March 31, 2015, the Company had net operating loss carryforwards for tax purposes of $542,714 which will expire beginning in 2031, if not previously utilized.

RELATED_PARTY_TRANSACTIONS_AND

RELATED PARTY TRANSACTIONS AND COMMITMENTS	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS AND COMMITMENTS	NOTE 6                          RELATED PARTY TRANSACTIONS AND COMMITMENTS
	On January 15, 2013, the Company entered into a convertible advance with the Company's Chief Executive Officer and Chairman. The advance, with a face value of $300,000, bears interest at 5% per annum and is payable on demand. The advance is convertible, at the holder's option, into the Company's common or preferred shares based on the value of the shares at the execution date of the advance.  The convertible advance is valued at the greater of the face value of the advance or the fair value of the shares, if converted.  At March 31, 2015 and December 31, 2014, the convertible advance was recorded at $241,908 and $221,908, respectively.  Accrued interest related to this advance was $8,405 and $5,423 at March 31, 2015 and December 31, 2014, respectively, and is included in accounts payable and accrued expenses on the consolidated balance sheets.
	The Company has exclusive rights to the Licensing Agreement with NHIL, the Company's majority shareholder, in which its wholly-owned subsidiary, GGII, assumes the financial responsibility for the acquisition and maintenance of all patents, as well as USDA's approval of Vaccines.

CONTINGENCIES

CONTINGENCIES	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	NOTE 7                          CONTINGENCIES
	During the normal course of business, the Company may be exposed to litigation.  When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with ASC 450-20-50, Contingencies.  The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome.  If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals.  As of March 31, 2015, the Company is not aware of any contingent liabilities that should be reflected in the accompanying consolidated financial statements.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
	The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") on the accrual basis of accounting.  All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements.  The significant accounting policies, estimates and related judgments underlying the Company's consolidated financial statements are summarized below.  In applying these policies, management makes subjective judgments that frequently require estimates about matters that are inherently uncertain.  Actual results could differ materially from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all investments with a maturity date of three months or less when purchased to be cash equivalents.  There were no cash equivalents at March 31, 2015 and December 31, 2014.
Revenue Recognition	Revenue Recognition
	The Company recognizes revenue on arrangements in accordance with Securities and Exchange Commission Staff Accounting Bulletin Topic 13, Revenue Recognition and ASC 605-15-25, Revenue Recognition.  In all cases, revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed and collectability is reasonably assured. The Company did not report any revenues for the periods ended March 31, 2015 and 2014.
Earnings Per Share	Earnings Per Share
	The Company has adopted ASC 260-10-50, Earnings Per Share, which provides for the calculation of "basic" and "diluted" earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Basic and diluted losses per share were the same at the reporting dates as there were no common stock equivalents outstanding at March 31, 2015 and 2014.
Concentrations	Concentrations
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash.
	Occasionally, cash balances may exceed amounts insured by the Federal Deposit Insurance Corporation ("FDIC").  Accordingly, the Company places its cash and cash equivalents with financial institutions considered by management to be of high credit quality.
Income Taxes	Income Taxes
	Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Additionally, the recognition of future tax benefits, such as net operating loss carryforwards, is required to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the assets and liabilities are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income tax expense in the period that includes the enactment date.
	In the event the future tax consequences of differences between the financial reporting bases and the tax bases of the Company's assets and liabilities result in deferred tax assets, an evaluation of the probability of being able to realize the future benefits indicated by such asset is required. A valuation allowance is provided for the portion of the deferred tax asset when it is more likely than not that some or all of the deferred tax asset will not be realized. In assessing the realizability of the deferred tax assets, management considers the scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies.
	The Company files income tax returns in the United States and Florida, which are subject to examination by the tax authorities in these jurisdictions. Generally, the statute of limitations related to the Company's federal and state income tax return is three years. The state impact of any federal changes for prior years remains subject to examination for a period up to five years after formal notification to the states.
	Management has evaluated tax positions in accordance with ASC 740, Income Taxes, and has not identified any significant tax positions, other than those disclosed.
Subsequent Events	Subsequent Events
	In accordance with ASC 855, Subsequent Events, the Company evaluated subsequent events through May 8, 2015, the date the consolidated financial statements were available for issue.

INTANGIBLE_ASSET_Tables

INTANGIBLE ASSET (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of components of intangible assets		31-Mar-15			31-Dec-14
	License Agreement	$	6,831		$	6,831
	Accumulated amortization		(1,456	)		(1,372	)
	Intangible assets, net	$	5,375		$	5,459

TAXES_Tables

TAXES (Tables)	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of components of income tax benefit		31-Mar-15			31-Mar-14
	Current tax benefit	$	(9,114	)	$	(7,609	)
	Change in valuation allowance		9,114			7,609
		$	-		$	-
Schedule of difference between income tax expense computed by applying the statutory federal income tax rate
		31-Mar-15			31-Mar-14
	Pretax loss at federal statutory rate	$	(8,241	)	$	(6,881	)
	State income benefit, net of federal benefit		(873	)		(729	)
	Change in valuation allowance		9,114			7,609
		$	-		$	-
Schedule of components of deferred taxes		31-Mar-15			31-Dec-14
	Deferred income tax assets:
	Operating loss carryforwards	$	204,062		$	194,948
	Less: Valuation allowance		(204,062	)		(194,948	)
		$	-		$	-

NATURE_OF_ORGANIZATION_Detail_

NATURE OF ORGANIZATION (Detail Textuals) (Nutritional Health Institute, LLC ("NHIL"))	1 Months Ended
In Millions, unless otherwise specified	Nov. 29, 2010
Licensing Agreement | Global Green International Inc
Nature Of Organization [Line Items]
Percentage of issued and outstanding stock acquired	100.00%
Share Exchange Agreement
Nature Of Organization [Line Items]
Common stock shares issued under acquisition	683
Percentage of ownership acquired	93.00%
Share Exchange Agreement | Global Green International Inc
Nature Of Organization [Line Items]
Percentage of issued and outstanding stock acquired	100.00%

GOING_CONCERN_Detail_Textuals

GOING CONCERN (Detail Textuals) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Going Concern [Abstract]
Accumulated net losses since inception	($542,714)	($518,475)
Net working capital deficit	$255,058

INTANGIBLE_ASSET_Components_of

INTANGIBLE ASSET - Components of intangible assets (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
License Agreement	$6,831	$6,831
Accumulated amortization	-1,456	-1,372
Intangible assets, net	$5,375	$5,459

INTANGIBLE_ASSET_Detail_Textua

INTANGIBLE ASSET (Detail Textuals) (USD $)	3 Months Ended		1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Nov. 29, 2010
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$84	$84
Amortization expense for each of next five year	$336
Licensing Agreement
Finite-Lived Intangible Assets [Line Items]
Useful life of the patent			20 years
Licensing Agreement | Nutritional Health Institute, LLC ("NHIL") | Global Green International Inc
Finite-Lived Intangible Assets [Line Items]
Percentage of issued and outstanding stock acquired			100.00%

TAXES_Components_of_income_tax

TAXES - Components of income tax benifit (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
components of income tax benefit
Current tax benefit	($9,114)	($7,609)
Change in valuation allowance	9,114	7,609
Income tax expense

TAXES_The_difference_between_i

TAXES - The difference between income tax expense computed by applying the statutory federal income tax rate to earnings before taxes (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Pretax loss at federal statutory rate	($8,241)	($6,881)
State income benefit, net of federal benefit	-873	-729
Change in valuation allowance	9,114	7,609
Income tax expense

TAXES_Components_of_deferred_t

TAXES - Components of deferred taxes (Details 2) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Deferred income tax assets:
Operating loss carryforwards	$204,062	$194,948
Less: Valuation allowance	-204,062	-194,948
Net deferred tax asset

TAXES_Detail_Textuals

TAXES (Detail Textuals) (USD $)	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$542,714

RELATED_PARTY_TRANSACTIONS_AND1

RELATED PARTY TRANSACTIONS AND COMMITMENTS (Detail Textuals) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Jan. 15, 2013
Related Party Transaction [Line Items]
Convertible advance - related party	$241,908	$221,908
Chief Executive Officer And Chairman | Convertible advance
Related Party Transaction [Line Items]
Convertible advance, face value			300,000
Convertible advance, interest rate			5.00%
Convertible advance - related party	241,908	221,908
Chief Executive Officer And Chairman | Convertible advance | Accounts payable and accrued liabilities
Related Party Transaction [Line Items]
Accrued interest	$8,405	$5,423